Previous studies suggested that EPA and DHA supplementation could reduce the expression of multiple inflammatory markers involved in the pathogenesis of osteoporosis, such as CRP, IL-6, and TNF-α (59–63). The gene discussed is CRP; the disease is osteoporosis.